Encapsulated papillary carcinoma of the breast: An institutional case series and literature review

Author:

Tan Hiang Jin12ORCID,Tan Puay Hoon34,Leong Lester Chee Hao5,Tan Veronique Kiak Mien1246,Tan Benita Kiat Tee12467,Lim Sue Zann1246,Preetha Madhukumar1246,Wong Chow Yin124,Yong Wei Sean1246,Sim Yirong1246

Affiliation:

1. SingHealth Duke‐NUS Breast Centre Singapore Singapore

2. Department of Breast Surgery Singapore General Hospital Singapore Singapore

3. Division of Pathology Singapore General Hospital Singapore Singapore

4. Duke‐NUS Medical School Singapore Singapore

5. Department of Diagnostic Radiology Singapore General Hospital Singapore Singapore

6. Division of Surgery and Surgical Oncology National Cancer Centre Singapore Singapore Singapore

7. Department of General Surgery (Breast service) Sengkang General Hospital Singapore Singapore

Abstract

AbstractBackgroundEncapsulated papillary carcinoma of the breast is rare, making difficult diagnosis and resulting in patients undergoing excision biopsy before definitive surgery. Evidence‐based guidelines are sparse. We would like to further elucidate the clinicopathological, treatment and survival outcomes.Materials and Methods54 patients identified, with a median follow up duration of 48 months. Patients' demographics, radiological and clinicopathological characteristics, treatment, adjuvant therapies as well as survival data were analysed.Results18 (33.3%) cases were pure EPC, 12 (22.2%) were EPC associated with ductal carcinoma in situ (DCIS) and 24 (44.4%) cases had concurrent invasive ductal carcinoma. EPCs were more likely to present as a solid‐cystic mass on sonography (63.8%), regular‐shaped (oval or round) (97.9%), lack spiculations (95.7%) and lack suspicious microcalcifications (95.6%). Median tumour size was largest in the EPC with IDC group (18.5 mm). 2 patients developed loco‐regional recurrence. Overall survival is good for EPCs of all subtypes.ConclusionEPC is a rare tumour with excellent prognosis.

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3